Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 464

1.
2.

Immunogenicity and functional evaluation of iPSC-derived organs for transplantation.

Wang L, Cao J, Wang Y, Lan T, Liu L, Wang W, Jin N, Gong J, Zhang C, Teng F, Yan G, Li C, Li J, Wan H, Hu B, Li W, Zhao X, Qi Z, Zhao T, Zhou Q.

Cell Discov. 2015 Jul 7;1:15015. doi: 10.1038/celldisc.2015.15. eCollection 2015.

3.

Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.

Hu S, Zhao MT, Jahanbani F, Shao NY, Lee WH, Chen H, Snyder MP, Wu JC.

JCI Insight. 2016 Jun 2;1(8). pii: e85558.

4.

The effects of cytosine methylation on general transcription factors.

Jin J, Lian T, Gu C, Yu K, Gao YQ, Su XD.

Sci Rep. 2016 Jul 7;6:29119. doi: 10.1038/srep29119.

5.

Regulation of the DNA Methylation Landscape in Human Somatic Cell Reprogramming by the miR-29 Family.

Hysolli E, Tanaka Y, Su J, Kim KY, Zhong T, Janknecht R, Zhou XL, Geng L, Qiu C, Pan X, Jung YW, Cheng J, Lu J, Zhong M, Weissman SM, Park IH.

Stem Cell Reports. 2016 Jul 12;7(1):43-54. doi: 10.1016/j.stemcr.2016.05.014. Epub 2016 Jun 30.

6.

Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.

Tousley A, Kegel-Gleason KB.

J Huntingtons Dis. 2016 Jun 28;5(2):99-131. doi: 10.3233/JHD-160199.

7.

The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.

Tesarova L, Simara P, Stejskal S, Koutna I.

PLoS One. 2016 Jun 23;11(6):e0157974. doi: 10.1371/journal.pone.0157974. eCollection 2016.

8.

Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome.

Darville H, Poulet A, Rodet-Amsellem F, Chatrousse L, Pernelle J, Boissart C, Héron D, Nava C, Perrier A, Jarrige M, Cogé F, Millan MJ, Bourgeron T, Peschanski M, Delorme R, Benchoua A.

EBioMedicine. 2016 Jul;9:293-305. doi: 10.1016/j.ebiom.2016.05.032. Epub 2016 May 27.

9.
10.

Unique cell-type-specific patterns of DNA methylation in the root meristem.

Kawakatsu T, Stuart T, Valdes M, Breakfield N, Schmitz RJ, Nery JR, Urich MA, Han X, Lister R, Benfey PN, Ecker JR.

Nat Plants. 2016 Apr 29;2(5):16058. doi: 10.1038/nplants.2016.58.

PMID:
27243651
11.

Establishment of Human Neural Progenitor Cells from Human Induced Pluripotent Stem Cells with Diverse Tissue Origins.

Fukusumi H, Shofuda T, Bamba Y, Yamamoto A, Kanematsu D, Handa Y, Okita K, Nakamura M, Yamanaka S, Okano H, Kanemura Y.

Stem Cells Int. 2016;2016:7235757. doi: 10.1155/2016/7235757. Epub 2016 Apr 26.

12.

Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.

Galat V, Galat Y, Perepitchka M, Jennings LJ, Iannaccone PM, Hendrix MJ.

Stem Cells Dev. 2016 Jul 15;25(14):1060-72. doi: 10.1089/scd.2015.0366. Epub 2016 Jun 27.

13.

CMD kinetics and regenerative medicine.

Anjamrooz SH.

Am J Transl Res. 2016 Mar 15;8(3):1615-24. eCollection 2016.

14.

The landscape of DNA methylation amid a perfect storm of autism aetiologies.

Ciernia AV, LaSalle J.

Nat Rev Neurosci. 2016 Jul;17(7):411-23. doi: 10.1038/nrn.2016.41. Epub 2016 May 6.

PMID:
27150399
15.

Diabetes treatment: A rapid review of the current and future scope of stem cell research.

Sheik Abdulazeez S.

Saudi Pharm J. 2015 Sep;23(4):333-40. doi: 10.1016/j.jsps.2013.12.012. Epub 2013 Dec 24. Review.

16.

Trisomy 21 Alters DNA Methylation in Parent-of-Origin-Dependent and -Independent Manners.

Alves da Silva AF, Machado FB, Pavarino ÉC, Biselli-Périco JM, Zampieri BL, da Silva Francisco Junior R, Mozer Rodrigues PT, Terra Machado D, Santos-Rebouças CB, Gomes Fernandes M, Chuva de Sousa Lopes SM, Lopes Rios ÁF, Medina-Acosta E.

PLoS One. 2016 Apr 21;11(4):e0154108. doi: 10.1371/journal.pone.0154108. eCollection 2016.

17.

Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease.

Yu H, Cowan CA.

Mol Endocrinol. 2016 Jun;30(6):575-86. doi: 10.1210/me.2015-1290. Epub 2016 Apr 13.

PMID:
27075706
18.

Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy.

Rami F, Mollainezhad H, Salehi M.

Genet Res Int. 2016;2016:3451807. doi: 10.1155/2016/3451807. Epub 2016 Feb 25. Review.

19.

Mitochondria in pluripotent stem cells: stemness regulators and disease targets.

Folmes CD, Ma H, Mitalipov S, Terzic A.

Curr Opin Genet Dev. 2016 Mar 5;38:1-7. doi: 10.1016/j.gde.2016.02.001. [Epub ahead of print] Review.

PMID:
26953561
20.

An integrative analysis of reprogramming in human isogenic system identified a clone selection criterion.

Shutova MV, Surdina AV, Ischenko DS, Naumov VA, Bogomazova AN, Vassina EM, Alekseev DG, Lagarkova MA, Kiselev SL.

Cell Cycle. 2016;15(7):986-97. doi: 10.1080/15384101.2016.1152425.

PMID:
26919644
Items per page

Supplemental Content

Write to the Help Desk